Bloomberg Talks · · 9 min
Telsey Advisory Group Founder Dana Telsey Talks GLP-1s
With Dana Telsey
Summary
Dana Telsey of Telsey Advisory Group discusses how GLP-1 weight-loss drugs are reshaping US consumer spending, with about 11% of adults now using them and use still rising, especially among women. She argues the drugs act as a spending accelerant, lifting purchases of protein and food, new clothing, skin care, gym memberships, dining out and beauty treatments, as well as gifts for users. Her firm forecasts 5% to 5.5% holiday sales growth, with GLP-1-driven spending offsetting promotion normalization and inflation. On Tiffany, she is bullish, citing growth since the merger, store remodels lifting sales, younger buyers embracing icon collections, and a recovery in bridal. She also notes that apparel is shifting from COVID-era athleisure toward occasion and fashion wear, while lab-grown diamonds' price gap has not eliminated demand for natural stones.
Key takeaways
- Dana Telsey on US consumer: Telsey forecasts US holiday sales growth of 5% to 5.5%, a solid rise on last year.
- Dana Telsey on GLP-1s & obesity drugs: GLP-1 users are driving spending across food, apparel, beauty and fitness, making GLP-1s a consumer accelerant.
- Dana Telsey on GLP-1s & obesity drugs: Oral GLP-1 dosing and falling prices should widen the user base beyond people who would inject.
- Dana Telsey (bullish on Tiffany & Co.): Tiffany is growing faster post-merger than as a public company, with remodels lifting sales.
- Dana Telsey on Consumer & retail: Lab-grown diamonds are far cheaper, but natural stones keep demand for authenticity.
What was said, by company and theme
6 views from 1 speaker. Every quote is checked against the episode's transcript (how).
Tiffany & Co.
Dana Telsey · Telsey Advisory GroupBullish
Tiffany is growing faster post-merger than as a public company, with remodels lifting sales.
Tiffany's growth rates have been higher since the merger than when it was a public company. Its icon collections are being accepted by younger generations. At least 40% of stores have been remodeled and are getting a sales lift, and the Blue Box Cafe is hard to book after the South Coast Plaza remodel. Watches and jewelry are gaining share, with bridal improving as couples who did not date during COVID get engaged.
“I think it's going well so far. You think about the growth rates that it's had. It's growing faster than it did when it was its own public company.”at 3:29
GLP-1s & obesity drugs
Dana Telsey · Telsey Advisory Group
GLP-1 users are driving spending across food, apparel, beauty and fitness, making GLP-1s a consumer accelerant.
About 11% of US adults now use GLP-1s, more women than men, and use is still rising given the health benefits shown. Users are changing spending across the lifestyle spectrum: protein and food, new clothing and size changes, skin care and moisturizers, gym workouts, dinners out and beauty treatments. Shoppers also buy gifts for people on the drugs, so GLP-1s are, in her view, a consumer accelerant for spending.
“GLP ones are definitely a consumer accelerant in terms of spending.”at 2:08
Dana Telsey · Telsey Advisory Group
Oral GLP-1 dosing and falling prices should widen the user base beyond people who would inject.
The shift from injections to oral dosage should open the market to many people who did not want to inject. Costs are also falling while health benefits increase, which she sees as a further reason adoption will keep growing.
“I would think that would open up the market to a whole ton of people that maybe did not wanna inject. ... It's getting cheaper. The cost of GLP ones is coming down.”at 2:23
Consumer & retail
Dana Telsey · Telsey Advisory Group
Lab-grown diamonds are far cheaper, but natural stones keep demand for authenticity.
The cost gap between lab-grown and natural diamonds is very large, and lab-grown stones come in bigger sizes. Even so, buyers still want authenticity and natural stones. She points to bridal demand picking up as evidence of a return to natural, and to Japanese buyers favoring smaller, higher-quality pieces.
“The cost differential is definitely vast with lab grown, and you can get larger stone sizes for lab grown. However, there's still a demand for authenticity and natural stones.”at 5:09
Dana Telsey · Telsey Advisory Group
Activewear is slowing while fashion and occasion wear grows as people dress up again.
The COVID-era athleisure trend, when people worked on Zoom, has faded. Activewear has slowed while fashion and occasion wear has grown. She cites people dressing up for events, suits returning without ties, dresses, skirts and brown suede boots as examples of the shift.
“activewear has slowed, fashion and occasion wear has grown. People are dressing up.”at 6:32
US consumer
Dana Telsey · Telsey Advisory Group
Telsey forecasts US holiday sales growth of 5% to 5.5%, a solid rise on last year.
Her firm's holiday sales forecast calls for 5% to 5.5% growth, a good number versus last year. Promotions are normalizing and inflation is present, which are headwinds, but GLP-1-driven gift buying and spending on new clothing, beauty and dining out is a tailwind she expects to lift the season.
“we came out with our holiday sales forecast of five to five and a half percent, which is a good forecast”at 1:29
Topics
- GLP-1 adoption and pricing
- GLP-1 knock-on effects on consumer spending
- Tiffany post-merger performance
- apparel category mix
- holiday sales outlook
- lab-grown vs natural diamonds
More from Bloomberg Talks
- Arora Group Founder Surinder Arora Talks UK's Business Outlook · October 30, 2026
- Earnings Special: Intel Plunges on PC Sales Slump & Amazon Slips · October 29, 2026
- Charles Schwab CEO Rick Wurster Talks Future of AI · October 29, 2026
- NEC Director Kevin Hassett Talks US Economy · October 29, 2026
- Cisco Systems President & Chief Product Officer Jeetu Patel Talks AI Industry · October 29, 2026
Ask your AI about this episode
Chorus gives Claude, ChatGPT and other assistants every view from this episode and the rest of the market's podcasts. Ask who agrees, who changed their mind, and what else was said about the same companies.
Chorus reports what speakers said. It isn't investment advice. How Chorus works · About Chorus